Novo Nordisk Korea has recently launched two new type 2 diabetes drugs – Rybelsus and Ozempic – raising expectations among local doctors that the drug will become a game-changer for Korean patients."One of the most important aspects of treating type 2 diabetes is to reduce cardiovascular complicatio
AngioLab announced the results of the phase 2 McEye study of ALS-L1023, an investigational drug to treat wet age-related macular degeneration (AMD).The company explored the optimal dose of ALS-L1023 combined with ranibizumab (brand name: Lucentis) and evaluated the safety and efficacy in 126 patient
Hanmi Pharmaceutical said the company would start marketing its blockbuster hypertension drug Amosartan under the brand name Meiyaping in China in September. It marked the first homegrown blood pressure combination therapy to enter the Chinese market.The launch follows Beijing Hanmi Pharmaceutical,
GC Pharma said it obtained marketing approval for Rozetelpine, a four-drug combination treatment for hypertension/hyperlipidemia.Rozetelpine combines hypertension medicines telmisartan and amlodipine with hyperlipidemia drugs rosuvastatin and ezetimibe.GC Pharma confirmed Rozetelpine’s efficacy in a
Chong Kun Dang said it would exclusively market Baxter Korea’s Caelyx, a recurrent ovarian cancer treatment, in Korea. Under the contract, Chong Kun Dang will distribute, sell, and market Caelyx to Korean hospitals and clinics from July.“We will strategically conduct distribution, sales, and marketi
Genencell said that it has signed an exclusive distributorship agreement with Ordi Pharma FZ-LLC, a UAE-based pharmaceutical company, for the exclusive distribution rights of ES16001, an oral Covid-19 treatment, in Middle East countries and Turkey.Ordi Pharma is a subsidiary of DEM Pharmaceuticals,
Janssen has launched Rybrevant (ingredient: amivantamab), a treatment for non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutation, raising expectations for a new treatment option.Rybrevant, the first fully human-derived bispecific antibody approved
Daewoong Pharmaceutical said it has submitted a new drug application (NDA) for Fexuprazan, its gastroesophageal reflux treatment, to four Latin American countries -- Mexico, Chile, Ecuador, and Peru.Fexuprazan is undergoing a product approval process in eight countries, the company said.Daewoong sai
Korean pharmaceutical companies, including Hanmi Pharmaceutical, LG Chem, and Yuhan Corp., are accelerating efforts to develop a new obesity drug with a new mechanism of action, a report said.On Monday, Korea Biotechnology Industry Organization (Korea BIO) released a report titled “Global Trends of
SK Bioscience said that it exported the first batch of SKY Varicella, a chickenpox vaccine, to the Pan America Health Organization (PAHO), an international health organ under the United Nations.Along with UNICEF, PAHO is one of the world's largest vaccine suppliers and is responsible for the large-s
Boryung Corp. said it recorded the largest quarterly earnings in the first quarter of 2022 in its history, continuing a solid growth after 2021.The company’s sales and operating profit posted 170.6 billion won ($134.4 million), and 18.7 billion won in the first quarter, up 26 percent and 36 percent
Astellas Pharma, a multinational pharmaceutical company based in Japan, has released a report detailing the disadvantages of living with bladder cancer and its psychological impact.Bladder cancer is the fifth most common cancer globally, with 151,000 new cases diagnosed in Europe alone every year. H
The drug regulator ordered Samsung Pharm to suspend manufacturing of hypertension drug Amonepin Tab. (ingredient: amlodipine maleate), saying the drugmaker violated the Good Manufacturing Practices (GMP).On Friday, the Ministry of Food and Drug Safety said Samsung Pharm received a four-month suspens
Chong Kun Dang said that it has entered into a strategic partnership with ENCell to conduct joint research on innovative drugs.Under the accord, Chong Kun Dang will conduct cell and gene therapy research and development by using ENCell's cell and gene therapy development know-how and production tech
Pfizer’s Lorviqua (ingredient: lorlatinib), the only third-generation anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor (TKI) usable for patients who failed the second-generation ALK TKI, obtained expanded indication as the first-line therapy to treat ALK-positive metastatic non-small cell
SK Biopharmaceuticals said that it would make a joint investment with SK Inc., an SK Group subsidiary specializing in investment, into Cala Health, a U.S.-based digital therapy company.Starting with this investment, the company plans to continue making strategic investments in cutting-edge biopharma
Chong Kun Dang released the findings of European phase 1 and pre-clinical trials of CKD-510, an investigational drug for Charcot-Marie-Tooth, at the annual meeting of the Peripheral Nerve Society (PNS), held in Miami from May 14-17.According to the company, CKD-510 uses non-hydroxamic acid platform
Huons Global said that the board of directors has approved the establishment of the company's branch in Japan, Huons Japan Co., Ltd.The new subsidiary, located in Osaka, will be responsible for expanding exports to Japan and locally distributing and selling Huons Group's healthcare portfolio, includ
Vivizon Pharmaceutical said it would lower the prices of 45 medicines from May 23.The announcement follows the Supreme Court’s recent order to lower drug prices. The Ministry of Health and Welfare also noticed changing the maximum reimbursement rates for Vivozon drugs.The court ordered Vivozon’s dru
Genencell said that it has started administering ES16001, an oral Covid-19 treatment candidate, to patients participating in its global phase 2 and 3 clinical trials. The clinical trial is for male and female patients 19 years or older who have tested positive for Covid-19.The company has registered